EUVIMEDEUVIMED entdecken
Crossref

Targeting AnxA2-EGFR signaling: hydroxychloroquine as a therapeutic strategy for bleomycin-induced pulmonary fibrosis

Vinay C Sangamesh, Dhananjay B Alagundagi, Pavan K Jayaswamy, Nithin Kuriakose, Praveenkumar Shetty

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025-02 · 398 (2) · 2015-2026

DOI: 10.1007/s00210-024-03417-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 02.09.2024. Verfasst von Vinay C Sangamesh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Nitte University Centre for Science Education and Research, Nitte (Deemed to Be University), Deralakatte, Mangalore, 575018, Karnataka, India. Hauptthemen laut MEDLINE: Hydroxychloroquine, ErbB Receptors, Annexin A2, Pulmonary Fibrosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydroxychloroquineErbB ReceptorsAnnexin A2Pulmonary FibrosisIdiopathic Pulmonary FibrosisAntifibrotic AgentsAnimalsBleomycinSignal TransductionMiceMaleMice, Inbred C57BLLungDisease Models, AnimalIndoles

Stichwörter der Autor:innen

AnnexinA2EGFRGalectin-3HydroxychloroquineLung

Substanzen

BleomycinHydroxychloroquineErbB ReceptorsAnnexin A2EGFR protein, mouseIndolesAntifibrotic Agentsnintedanib

Autor:innen und Institutionen

  • Nitte University Centre for Science Education and Research, Nitte (Deemed to Be University), Deralakatte, Mangalore, 575018, Karnataka, India.
  • Central Research Laboratory, KS. Hegde Medical Academy, Nitte (Deemed to Be University), Deralakatte, Mangalore, 575018, Karnataka, India.
  • Central Research Laboratory, KS. Hegde Medical Academy, Nitte (Deemed to Be University), Deralakatte, Mangalore, 575018, Karnataka, India. praveenkumarshetty@nitte.edu.in.
  • Department of Biochemistry, K.S. Hegde Medical Academy, Nitte (Deemed to Be University), Deralakatte, Mangalore, 575018, Karnataka, India. praveenkumarshetty@nitte.edu.in.

Zitieren

APA

Sangamesh, V. C., Alagundagi, D. B., Jayaswamy, P. K., Kuriakose, N., & Shetty, P. (2025). Targeting AnxA2-EGFR signaling: hydroxychloroquine as a therapeutic strategy for bleomycin-induced pulmonary fibrosis. Naunyn-Schmiedeberg's Archives of Pharmacology, 398(2), 2015-2026. https://doi.org/10.1007/s00210-024-03417-9

Vancouver

Sangamesh VC, Alagundagi DB, Jayaswamy PK, Kuriakose N, Shetty P. Targeting AnxA2-EGFR signaling: hydroxychloroquine as a therapeutic strategy for bleomycin-induced pulmonary fibrosis. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025;398(2):2015-2026. doi:10.1007/s00210-024-03417-9

BibTeX
@article{Sangamesh2025,
  author = {Sangamesh, Vinay C and Alagundagi, Dhananjay B and Jayaswamy, Pavan K and Kuriakose, Nithin and Shetty, Praveenkumar},
  title = {Targeting AnxA2-EGFR signaling: hydroxychloroquine as a therapeutic strategy for bleomycin-induced pulmonary fibrosis},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  volume = {398},
  number = {2},
  pages = {2015--2026},
  doi = {10.1007/s00210-024-03417-9}
}
Kostenlos starten →